Literature DB >> 3674847

Antifungal activity of the allylamine derivative terbinafine in vitro.

G Petranyi1, J G Meingassner, H Mieth.   

Abstract

Terbinafine, an allylamine derivative, represents the most effective of this new chemical class of antimycotic compounds. Under in vitro conditions, terbinafine proved to be highly active against dermatophytes (MIC range, 0.001 to 0.01 microgram/ml), aspergilli (MIC range, 0.05 to 1.56 micrograms/ml), and Sporothrix schenckii (MIC range, 0.1 to 0.4 microgram/ml) and also exerted good activity against yeasts (MIC range, 0.1 to greater than 100 micrograms/ml). The growth of Malassezia furfur was inhibited also (MIC range, 0.2 to 0.8 microgram/ml). Terbinafine displays a primary fungicidal action against dermatophytes, other filamentous fungi, and S. schenckii. The type of action against yeasts is species dependent and can be primarily fungicidal (Candida parapsilosis) or fungistatic (Candida albicans). The in vitro activity of terbinafine is pH dependent and rises with increasing pH value.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3674847      PMCID: PMC174943          DOI: 10.1128/AAC.31.9.1365

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  11 in total

1.  In-vitro studies with SF 86-327, a new orally active allylamine derivative.

Authors:  S Shadomy; A Espinel-Ingroff; R J Gebhart
Journal:  Sabouraudia       Date:  1985-04

2.  [Deep-freeze preservation of fungi in liquid nitrogen as a basis for standardized inocula].

Authors:  A Georgopoulos
Journal:  Mykosen       Date:  1978-01

3.  In vivo antimycotic activity of naftifine.

Authors:  G Petranyi; A Georgopoulos; H Mieth
Journal:  Antimicrob Agents Chemother       Date:  1981-03       Impact factor: 5.191

4.  In vitro activity of naftifine, a new antifungal agent.

Authors:  A Georgopoulos; G Petranyi; H Mieth; J Drews
Journal:  Antimicrob Agents Chemother       Date:  1981-03       Impact factor: 5.191

5.  [In vitro spectrum of action of a new antifungal derivative of naftifin: terbinafin (SF 86-327)].

Authors:  M Goudard; Y Buffard; H Ferrari; P Regli
Journal:  Pathol Biol (Paris)       Date:  1986-06

6.  Synthesis and structure-activity relationships of naftifine-related allylamine antimycotics.

Authors:  A Stütz; A Georgopoulos; W Granitzer; G Petranyi; D Berney
Journal:  J Med Chem       Date:  1986-01       Impact factor: 7.446

7.  Allylamine derivatives: new class of synthetic antifungal agents inhibiting fungal squalene epoxidase.

Authors:  G Petranyi; N S Ryder; A Stütz
Journal:  Science       Date:  1984-06-15       Impact factor: 47.728

8.  Inhibition of squalene epoxidase by allylamine antimycotic compounds. A comparative study of the fungal and mammalian enzymes.

Authors:  N S Ryder; M C Dupont
Journal:  Biochem J       Date:  1985-09-15       Impact factor: 3.857

9.  Tinea versicolor and Pityrosporum orbiculare: mycological investigations, experimental infections and epidemiological surveys.

Authors:  J Faergemann
Journal:  Acta Derm Venereol Suppl (Stockh)       Date:  1979

10.  Specific inhibition of fungal sterol biosynthesis by SF 86-327, a new allylamine antimycotic agent.

Authors:  N S Ryder
Journal:  Antimicrob Agents Chemother       Date:  1985-02       Impact factor: 5.191

View more
  35 in total

1.  Ultrastructural alterations induced by two ergosterol biosynthesis inhibitors, ketoconazole and terbinafine, on epimastigotes and amastigotes of Trypanosoma (Schizotrypanum) cruzi.

Authors:  K Lazardi; J A Urbina; W de Souza
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191

2.  Pharmacokinetics of oral terbinafine in horses and Greyhound dogs.

Authors:  M M Williams; E G Davis; B KuKanich
Journal:  J Vet Pharmacol Ther       Date:  2011-06       Impact factor: 1.786

3.  Development of a tightly regulatable copper-mediated gene switch system in dermatophytes.

Authors:  Atsushi Iwata; Mohamed Mahdi Alshahni; Yayoi Nishiyama; Koichi Makimura; Shigeru Abe; Tsuyoshi Yamada
Journal:  Appl Environ Microbiol       Date:  2012-05-18       Impact factor: 4.792

4.  Oral terbinafine for treatment of pulmonary Pseudallescheria boydii infection refractory to itraconazole therapy.

Authors:  P E Verweij; N J Cox; J F Meis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-01       Impact factor: 3.267

5.  In vitro activities of terbinafine in combination with fluconazole and itraconazole against isolates of Candida albicans with reduced susceptibility to azoles.

Authors:  F Barchiesi; L Falconi Di Francesco; G Scalise
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

6.  In vitro antifungal activity of KP-103, a novel triazole derivative, and its therapeutic efficacy against experimental plantar tinea pedis and cutaneous candidiasis in guinea pigs.

Authors:  Y Tatsumi; M Yokoo; T Arika; H Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

Review 7.  In vitro and in vivo evaluation of antifungal agents.

Authors:  A Espinel-Ingroff; S Shadomy
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-04       Impact factor: 3.267

8.  In vitro activities of terbinafine against cutaneous isolates of Candida albicans and other pathogenic yeasts.

Authors:  N S Ryder; S Wagner; I Leitner
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

9.  Iontophoretic terbinafine HCL 1.0% delivery across porcine and human nails.

Authors:  Boaz Amichai; Rachel Mosckovitz; Henri Trau; Orit Sholto; Shirly Ben-Yaakov; Michael Royz; David Barak; Boaz Nitzan; Avner Shemer
Journal:  Mycopathologia       Date:  2009-12-13       Impact factor: 2.574

10.  Comparison of terbinafine and clotrimazole in treating tinea pedis.

Authors:  E G Evans; B Dodman; D M Williamson; G J Brown; R G Bowen
Journal:  BMJ       Date:  1993-09-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.